Patent directory · USPTO A61K / A61P
Patents matching “antagonist”
678 pharma patents match "antagonist" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 678 pharmaceutical patents matching "antagonist" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12054487
Muscarinic acetylcholine M1 receptor antagonists
granted -
US 11986511
Use of a VEGF antagonist to treat angiogenic eye disorders
granted -
US 11975045
Use of a VEGF antagonist to treat angiogenic eye disorders
granted -
WO 2024081718
ANTAGONISTE DU RÉCEPTEUR CGRP POUR LE TRAITEMENT DE LA MIGRAINE
granted -
US 11944666
Treatment of inflammatory conditions delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 11926625
HPK1 antagonists and uses thereof
granted -
US 11912786
Inhibitor of apoptosis protein (IAP) antagonists
granted -
US 11897873
Kappa opioid receptor antagonists and products and methods related thereto
granted -
US 11890289
Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
granted -
US 11878074
Methods of use of emulsion formulations of an NK-1 receptor antagonist
granted -
US 11873291
Quinoline cGAS antagonist compounds
granted -
US 11866503
Methods for treating inflammatory conditions of the airway or lungs by administering antagonist monoclonal antibodies to interleukin-33 and interleukin-4 receptor
granted -
US 11858943
Vasopressin receptor antagonists and products and methods related thereto
granted -
US 11844765
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 11845800
Methods for treating or preventing asthma by administering an IL-4R antagonist
granted -
US 11840581
α4β7 thioether peptide dimer antagonists
granted -
US 11834409
Heterocyclic NMDA antagonists
granted -
US 11827601
Heterocyclic NMDA antagonists
granted -
US 11806398
Citrate buffered VEGF antagonist formulations
granted -
US 11771743
Methods for preventing or treating allergy by administering an IL-4R antagonist
granted -
US 11744800
Methods of use of emulsion formulations of an NK-1 receptor antagonist
granted -
US 11732024
VEGF antagonist formulations suitable for intravitreal administration
granted -
US 11730705
Small molecule CMKLR1 antagonists in inflammatory disease
granted -
US 11730794
Use of a VEGF antagonist to treat angiogenic eye disorders
granted